Eric H Bernicker

6PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 25, 2022
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.

Kai Sun, Yitian Xu, Licheng Zhang

|Dec 15, 2021
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.

Andrew W Chung, Kartik Anand, Ann C Anselme

|Apr 06, 2021
Adherence to National Comprehensive Cancer Network ALK Testing Guidelines for Patients with Advanced Non-Small Cell Lung Cancer in U.S. Community Medical Centers.

Eric H Bernicker, Yan Xiao, Anup Abraham

|Oct 14, 2018
Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer.

Sarah Croessmann, Luigi Formisano, Lisa N Kinch

Pageof 1

Frequent Collaborators

2 joint publications

Joan Schiller

2 joint publications

Jenny C Chang

2 joint publications

Nakul Gupta

2 joint publications

Polly Niravath